Based on this principle, Qiu et al. treated cancer cells expressing, naturally or by induction, MHC class II molecules and Ii protein, with anti-Ii ASO to induce the MHC-II–mediated presentation of diverse antigenic peptides to helper T cells (Figure 3). This evidence concerns the gene CD74 and cancer.